Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
ACOLBIFENE
Breast Carcinoma
National Cancer Institute (NCI)P2CCC (53)
ACOLBIFENE
Ductal Breast Carcinoma In Situ
National Cancer Institute (NCI)P2CCC (53)
ACOLBIFENE
Lobular Breast Carcinoma In Situ
National Cancer Institute (NCI)P2CCC (53)
ad5 cea vaccine
Colorectal Neoplasm
National Cancer Institute (NCI)P2CCC (53)
ad5 cea vaccine
Lynch Syndrome
National Cancer Institute (NCI)P2CCC (53)
Adenovirus 5 Cea/Muc1/Brachyury Vaccine Tri-Ad5
Colorectal Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Adenovirus 5 Cea/Muc1/Brachyury Vaccine Tri-Ad5
Lynch Syndrome
National Cancer Institute (NCI)P2CCC (53)
Alpelisib
Female Reproductive Organ Cancer
National Cancer Institute (NCI)P2CCC (53)
Alpelisib
Fallopian Tube Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Alpelisib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Anetumab Ravtansine
Fallopian Tube Endometrioid Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Anetumab Ravtansine
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Anetumab Ravtansine
Ovarian Endometrioid Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Anetumab Ravtansine
Ovarian Serous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Anetumab Ravtansine
Fallopian Tube Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Anetumab Ravtansine
Ovarian Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Anetumab Ravtansine
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Anetumab Ravtansine
Primary Peritoneal Serous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Chondrosarcoma
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Combined Hepatocellular Carcinoma And Cholangiocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Dedifferentiated Chondrosarcoma
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Diffuse Astrocytoma
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Hereditary Leiomyomatosis And Renal Cell Cancer
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Clear Cell Sarcoma
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Gallbladder Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Showing 1026 to 1050 of 3,272 assets
PreviousPage 42 of 131Next